Psoriatic Arthritis
Conference Coverage
Study offers reassuring data on certolizumab use in pregnancy
VIENNA – Consider off-label certolizumab in women with psoriasis who need a biologic and are pregnant or planning to become so.
Conference Coverage
What good are biosimilars if patients won’t use them?
BOSTON – The only meaningful measure of the success of biosimilar drugs for arthritis is whether patients use them.
Conference Coverage
FDA’s Woodcock: Give biosimilars a chance
BOSTON – Biosimilar drugs are not identical twins of original biologic agents, but there are very strong family ties, and the newcomer is expected...
Conference Coverage
Biosimilars face barriers to broader acceptance
BOSTON – For rheumatologists, the primary selling points of biosimilar agents are their presumed efficacy and safety, and their promised cost...
From the Journals
PsA bone loss measurement: A surrogate for radiographic progression?
An advanced computer assisted digital x-ray radiogrammetry technique that measures bone thickness has the potential to be a surrogate marker of...
Conference Coverage
Tildrakizumab for psoriasis scores high marks in phase III
VIENNA – Tildrakizumab, a novel biologic for moderate to severe psoriasis, showed favorable efficacy and safety outcomes in two pivotal phase III...
Conference Coverage
Secukinumab for psoriasis at 4 years: undiminished efficacy and safety
VIENNA – Secukinumab showed reassuring safety with no drop-off in efficacy for psoriasis after 4 years of treatment.
Conference Coverage
Guselkumab achieves highest-ever response rates in psoriasis
VIENNA
Conference Coverage
Birth outcomes unaffected by paternal immunosuppressive therapy
VIENNA - Paternal use of systemic immunosuppressive agents in the months prior to conception didn't result in increased risk of preterm birth,...
From the Journals
Severe joint pain in adults with arthritis continues to rise
The prevalence of severe joint pain among adults with diagnosed arthritis continues to increase, researchers from the CDC reported in the Oct. 7...
From the Journals
Most children with JIA get different diagnosis as adults
Two-thirds of children diagnosed with juvenile idiopathic arthritis are classified later as having a different form of arthritis as adults, with...